- Asked by: Martin Whitfield, MSP for South Scotland, Scottish Labour
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 7 October 2025
To ask the Scottish Government how it plans to meet the interim and final child poverty reduction targets, in light of the Joseph Rowntree Foundation’s finding in its report, Poverty in Scotland 2025, that current levels remain largely unchanged since 2021.
Answer
Taken in the Chamber on 7 October 2025
- Asked by: Jackie Dunbar, MSP for Aberdeen Donside, Scottish National Party
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 7 October 2025
To ask the Scottish Government whether it will provide an update regarding its response to Storm Amy.
Answer
Taken in the Chamber on 7 October 2025
- Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
To ask the First Minister what the Scottish Government’s response is to reports that the mental health budget has been reduced in the 2025-26 Autumn Budget Revision.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Clare Adamson, MSP for Motherwell and Wishaw, Scottish National Party
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
To ask the First Minister what assessment the Scottish Government has made of any implications for its work to mitigate the two-child benefit cap of the UK Government's reported proposals to replace the cap with a tapered system.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
To ask the First Minister, following Scotland’s Global Investment Summit 2025, whether he will provide an update on the Scottish Government’s work to attract international investment into Scotland’s economy.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Anas Sarwar, MSP for Glasgow, Scottish Labour
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
Question to be taken in Chamber.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Russell Findlay, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
Question to be taken in Chamber.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Alex Cole-Hamilton, MSP for Edinburgh Western, Scottish Liberal Democrats
-
Date lodged: Monday, 06 October 2025
-
Current Status:
Taken in the Chamber on 9 October 2025
Question to be taken in Chamber.
Answer
Taken in the Chamber on 9 October 2025
- Asked by: Stephen Kerr, MSP for Central Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 24 September 2025
-
Current Status:
Answered by Jenny Gilruth on 6 October 2025
To ask the Scottish Government what funding it has provided to the Massage In Schools Association Scotland in each of the last three years, and for what purposes.
Answer
The Scottish Government has provided no funding to the Massage in Schools Association Scotland.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Monday, 22 September 2025
-
Current Status:
Answered by Jenni Minto on 6 October 2025
To ask the Scottish Government what research it is undertaking into the potential (a) effectiveness and (b) cost-effectiveness of Calmare therapy in offering relief for conditions such as nerve pain, cancer pain, opioid-induced pain and chronic regional pain syndrome, and whether this therapy is being considered for routine commissioning to offer relief for such conditions.
Answer
The Scottish Government’s Chief Scientist Office (CSO) is responsible for supporting health and care research. The CSO runs a number of projects and fellowship funding schemes for Scottish-led research.
Applications on the potential (a) effectiveness and (b) cost-effectiveness of Calmare therapy are welcomed. In common with all applications, these would go through CSO's standard independent expert review process to enable funding decisions to be made.
In addition, through UK-wide funding arrangements, the majority of funding programmes administered by the National Institute for Health and Care Research (NIHR) are open to applications led by researchers based in Scotland.
We have asked NHS Research Scotland Networks for Musculoskeletal and Pain that might be expected to have Calmare therapy within their portfolios whether they are supporting any studies. Neither is currently doing so.